Researchers & Faculty
Japanese
TOP page
>
Faculty of Engineering Department of Electrical and Electronic Engineering
> Akira Takaguri
(Last updated : 2024-07-02 09:30:23)
Akira Takaguri
Department / Course
Hokkaido University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy
Job
Associate Professor
Achievement
Academic background
Present specialized field
Book and thesis
Academic conference presentation
Academic background
2009/03
Degree Acquisition
2006/03
Degree Acquisition
Present specialized field
Pharmacology
Book and thesis
Papers
Epalrestat enhances MTS reduction activity independent of cell numbers in bovine aortic endothelial cells Pharmacology and Pharmacy (Co-authored) 2023/02
Papers
Rational design and structure-activity relationship studies reveal new esterified C20-diterpenoid alkaloid analogues active against MCF-7 human breast cancer cells (Co-authored) 2023
Papers
The role of tribbles homolog 2 in vascular smooth muscle cell proliferation (Co-authored) 2023
Papers
Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms Cardiovascular Drugs Ther (Co-authored) 2022/02
Papers
Involvement of circadian clock gene BMAL1 in doxorubicin-induced inflammation in vascular smooth muscle cells Pharmacology and Pharmacy 12 (11) (Co-authored) 2021/12
Display All(8)
Academic conference presentation
2014/11
A DISINTEGRIN AND METALLOPROTEASE 17, A POTENTIAL MEDIATOR OF INTERLEUKIN-1Α DEPENDENT INSULIN RESISTANCE IN L6 RAT SKELETAL MUSCLE CELLS (10th IDF-WPR and 6th AASD Scientific Meeting 2014)
2011
Constitutive stimulation of vascular smooth muscle cells by Angiotensin II derived from adenovirus encoding a furin-cleavable fusion membrane protein (The Federation of American Societies for Experimental Biology (Washington USA))
2011
Vascular Selective ADAM17 Silencing Prevented Medial Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II Infusion (High Blood Pressure Research 2011 Scientific Sessions (Orlando USA))
2011
Vascular Selective ADAM17 Silencing Prevented Medial Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II Infusion. (AHA Scientific Sessions (Orlando USA))
2010
ADAM17 is a novel therapeutic target for vascular remodeling. (Gordon Research Conference (Ventura USA))
Display All(13)